The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review

Background: Irritable bowel syndrome (IBS) is a common gastrointestinal tract disorder, affecting 10–20% of adults worldwide. Mebeverine is an antispasmodic agent indicated for the symptomatic treatment of abdominal pain caused by intestinal smooth muscle spasms and intestinal functional disorders i...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniluk, Jaroslaw, Malecka-Wojciesko, Ewa, Skrzydlo-Radomanska, Barbara, Rydzewska, Grazyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879004/
https://www.ncbi.nlm.nih.gov/pubmed/35207315
http://dx.doi.org/10.3390/jcm11041044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879004/
https://www.ncbi.nlm.nih.gov/pubmed/35207315
http://dx.doi.org/10.3390/jcm11041044

Ejemplares similares